Advertisement

Leishmaniasis pp 271-279 | Cite as

Different Epitopes of the Macrophage Type Three Complement Receptor (CR3) Are Used to Bind Leishmania Promastigotes Harvested at Different Phases of Their Growth Cycle

  • Andrea Cooper
  • Anne O. Wozencraft
  • Tamara I. A. Roach
  • Jenefer M. Blackwell
Part of the NATO ASI Series book series (NSSA, volume 171)

Abstract

A number of studies1–4 have demonstrated that monoclonal antibodies (MAbs) directed against the type three complement receptor (CR3) block the binding and ingestion of Leishmania promastigotes by host macrophages. This receptor is known to recognise the inactivated form of complement factor 3 (iC3b)5 and to mediate direct leetin-like attachment of particles such as yeast zymosan. Binding via these different sites on CR3 may have important implications for parasite survival since ligation via the leetin-binding site stimulates release of antimicrobial reactive oxygen intermediates whereas ligation of iC3b does not6. In our earlier studies1 we had demonstrated that the anti-CR3 MAb M1/70, Fab-anti-C3, and the nucleophile sodium salicyl hydroxamate (Sana), which inhibits the covalent binding of C3 to an activator surface, all inhibited the serum-independent uptake of L. donovani promastigotes to equivalent degrees. This suggested that binding of promastigotes to CR3 was complement mediated, and was supported by our subsequent demonstration of Saha-inhibitable deposition of macrophage derived C3 on the promastigote surface7.

Keywords

Growth Cycle Complement Receptor Late Stationary Phase Host Macrophage Footpad Thickness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. M. Blackwell, R. A. B. Ezekowitz, M. B. Roberts, J. Y. Channon, R. B. Sim, and S. Gordon, Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med. 162:324 (1985).PubMedCrossRefGoogle Scholar
  2. 2.
    D. M. Mosser and P. J. Edelson, The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J. Immunol. 135:2785 (1985).PubMedGoogle Scholar
  3. 3.
    A. O. Wozencraft and J. M. Blackwell, Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages. Immunology 60:559 (1987).PubMedGoogle Scholar
  4. 4.
    M. E. Wilson and R. D. Pearson, The role of CR3 and mannose receptor in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect. Immun. (in press 1987).Google Scholar
  5. 5.
    D. I. Beller, T. A. Springer, and R. D. Schrieber, Anti Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156:1000 (1982).PubMedCrossRefGoogle Scholar
  6. 6.
    G. D. Ross, J. A. Cain, and P. J. Lachmann, Membrane complement receptor type three (CR3) has lectin like properties analogous to bovine conglutin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 134:3307 (1985).PubMedGoogle Scholar
  7. 7.
    A. O. Wozencraft, G. Sayers, and J. M. Blackwell, Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. J. Exp. Med. 164:1332 (1986).PubMedCrossRefGoogle Scholar
  8. 8.
    R. Killick-Kendrick, Biology of Leishmania in phlebotamine sandflies, in: “Biology of the Kinetoplastida” vol.2. W. H. R. Lumsden and D. A. Evans, eds. Academic Press, London (1979).Google Scholar
  9. 9.
    D. L. Sacks, S. Hieny, and A. Sher, Identification of cell surface carbohydrate and antigenic changes between non-infective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135:564 (1985).PubMedGoogle Scholar
  10. 10.
    M. K. Howard, G. Sayers, and M. A. Miles, Leishmania donovani metacyclic promastigotes: transfomation in vitro, lectin agglutination, complement resistance and infectivity. Exp. Parasitol. (in press, 1987).Google Scholar
  11. 11.
    D. L. Sacks and R. da Silva, The generation of infective stage Leishmania major promastigotes is associated with the cell surface expression and release of a developmentally regulated glycolipid. Submitted for publication.Google Scholar
  12. 12.
    M. Kweider, J-L. Lemesre, F. Darcy, J-P Kusnierz, A. Capron, and F. Santoro, Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000-dalton surface antigen. J. Immunol. 138: 299 (1987).PubMedGoogle Scholar
  13. 13.
    T. Springer, G. Galfre, D. S. Secher, and C. Milstien, Mac-1: a macrophage differentiation antigen identified by a monoclonal antibody. Eur. J. Imm. 9:301 (1979).CrossRefGoogle Scholar
  14. 14.
    H. Rosen and S. Gordon, Monoclonal antibody to the murine type three complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. (in press, 1987).Google Scholar
  15. 15.
    J. Y. Channon, M. B. Roberts, and J. M. Blackwell, A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology 53:345 (1984).PubMedGoogle Scholar
  16. 16.
    J. Alexander and K. Vickerman, Fusion of host cell secondary lysosmes with the parasitophorous vacuoles of Leishmania mexicana infected macrophages. J. Protozool. 22:502 (1975).PubMedCrossRefGoogle Scholar
  17. 17.
    B. A. Mock, A. H. Fortier, M. Potter, J. Blackwell, and C. A. Nacy, Control of systemic Leishmania major infection: identification of subline differences for susceptibility to disease. Curr. Top. Microbiol. Immunol. 122:115 (1985).PubMedCrossRefGoogle Scholar
  18. 18.
    D. J. Bradley and J. Kirkley, Regulation of Leishmania populations within the host: variable course of Leishmania donovani infection in mice. Clin. Exp. Immunol. 30:119 (1977).PubMedGoogle Scholar
  19. 19.
    R. da Silva and D. L. Sacks, Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect. Immun. (in press, 1987).Google Scholar
  20. 20.
    A. T. Remaley, D. B. Kuhns, R. E. Basford, R. H. Glew, and S. S. Kaplan, Leishmania phosphatase blocks neutrophil O2-production. J. Biol. Chem. 259:11173 (1984).PubMedGoogle Scholar
  21. 21.
    E. Handman and J. W. Goding, The Leishmania receptor for macrophages is a lipid containing glycoconjugate. EMBO J. 3:2301 (1985).Google Scholar
  22. 22.
    D. G. Russell and H. Wilhelm, The involvement of the major surface glycoprotien GP63 of Leishmania promastigotes in attachment to macrophages. J. Immunol. 136:2613 (1986).PubMedGoogle Scholar
  23. 23.
    S. M. Puentes, D L. Sacks, R. da Silva and K. A. Joiner, Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface glycolipid. Submitted for publication.Google Scholar
  24. 24.
    D. G. Russell, The macrophage-attachment glycoprotein GP63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes. Eur. J. Biochem 164:213 (1987).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Andrea Cooper
    • 1
  • Anne O. Wozencraft
    • 1
  • Tamara I. A. Roach
    • 1
  • Jenefer M. Blackwell
    • 1
  1. 1.Department of Tropical HygieneLondon School of Hygiene and Tropical MedicineLondonUK

Personalised recommendations